Holen Sie sich die Stockscreener-App
50.90
0.34%
-0.16
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
QIAGEN NV : Buy rating from Berenberg - marketscreener.com
QIAGEN Is Unleashing a Powerful Product Expansion Strategy — And It’s Reshaping Growth! - Smartkarma
Goldman Sachs Discloses 3.06% Stake in Qiagen via AFM Filing - TipRanks
Release according to Article 40, Section 1 of the WpHG - TradingView
UBS Adjusts QIAGEN Price Target to $52 From $50, Maintains Neutral Rating - marketscreener.com
Qiagen N.V. $QGEN Shares Sold by Nuance Investments LLC - MarketBeat
Qiagen N : Fourth Quarter 2025 Transcript - marketscreener.com
Entry Recap: Is Qiagen NV backed by strong institutional buyingWeekly Investment Report & Expert Verified Movement Alerts - baoquankhu1.vn
Qiagen targets 9% growth in 2026 growth pillars and $2B by 2028 with new product launches - MSN
Qiagen Q4 Earnings Call Highlights - MarketBeat
Qiagen N.V. (NYSE:QGEN) Q4 2025 Earnings Call Transcript - Insider Monkey
Qiagen (QGEN) PT Raised by JP Morgan Amid Overweight Rating | QG - GuruFocus
JPMorgan Chase & Co. Boosts Qiagen (NYSE:QGEN) Price Target to $60.00 - MarketBeat
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Stifel raises Qiagen stock price target to $50 on growth outlook By Investing.com - Investing.com South Africa
Citigroup Cuts Qiagen (NYSE:QGEN) Price Target to $55.00 - MarketBeat
QGEN Analyst Rating: Citigroup Maintains Neutral, Lowers Price T - GuruFocus
Qiagen (QGEN): Stifel Raises Price Target to $50, Maintains Hold Rating | QGEN Stock News - GuruFocus
Stifel raises Qiagen stock price target to $50 on growth outlook - Investing.com
Qiagen NV (QGEN) PT Raised to $50 at Stifel - StreetInsider
Qiagen: 2025 ended positively, entering 2026 with confidence - marketscreener.com
QGEN's Q4 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down - TradingView
Qiagen Tops 2025 Guidance and Sets Ambitious 2026 Growth Targets - TipRanks
QIAGEN (NYSE: QGEN) tops 2025 targets and guides for at least 5% CER sales growth in 2026 - Stock Titan
QIAGEN NV : Jefferies reaffirms its Buy rating - marketscreener.com
Jefferies Maintains Buy on Qiagen N.V. (QGEN) Feb 2026 - Meyka
Qiagen (QGEN) Exceeds Q4 2025 Expectations with Strong Financial Performance - GuruFocus
Qiagen NV (QGEN) Q4 2025 Earnings Call Highlights: Strong Growth Amidst Challenges - GuruFocus
Qiagen NV (QGEN) Q4 2025 Earnings Call Highlights: Strong Growth Amidst Challenges By GuruFocus - Investing.com Canada
Investors Purchase Large Volume of Call Options on Qiagen (NYSE:QGEN) - MarketBeat
Allianz Asset Management GmbH Purchases 534,527 Shares of Qiagen N.V. $QGEN - MarketBeat
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars - BioSpace
QIAGEN NV : Jefferies maintains a Buy rating - marketscreener.com
Goldman Sachs Reports 3.11% Stake in QIAGEN via Shares and Derivatives - The Globe and Mail
Qiagen reports Q4 sales USD 540 mln - marketscreener.com
BlackRock Discloses Significant Stake in QIAGEN - The Globe and Mail
Qiagen (QGEN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Qiagen: Q4 Financial Results Overview - Bitget
Qiagen (QGEN) Meets Q4 Earnings Estimates - Yahoo Finance
Qiagen (NYSE:QGEN) Announces Earnings Results - MarketBeat
Qiagen (NYSE:QGEN) Updates Q1 2026 Earnings Guidance - MarketBeat
Qiagen (NYSE:QGEN) Issues FY 2026 Earnings Guidance - MarketBeat
Qiagen: Q4 Earnings Snapshot - kare11.com
Qiagen guides to at least 5% sales growth in 2026 By Investing.com - Investing.com Nigeria
Qiagen guides to at least 5% sales growth in 2026 - Investing.com
Qiagen faces earnings test as analyst estimates slide 15% despite takeover chatter - Investing.com
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026 - BioSpace
Aug Mood: Should I set a stop loss on Qiagen N.VEarnings Overview Report & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Examining the Future: Qiagen's Earnings Outlook - Benzinga
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Strs Ohio Sells 33,555 Shares of Qiagen N.V. $QGEN - MarketBeat
€43.77 Qiagen (QIA.DE XETRA) intraday 03 Feb 2026 ahead of earnings: what to watch - Meyka
United States Molecular Diagnostics Market to Reach US$ 11.157 - openPR.com
Goldman Sachs Discloses 3.26% Voting Interest in QIAGEN - TipRanks
Qiagen N.V. (QGEN) Stock Analysis: Diagnostic Powerhouse With A 6.1% Revenue Growth - DirectorsTalk Interviews
Barclays Maintains Qiagen NV(QGEN.US) With Buy Rating, Cuts Target Price to $55 - 富途牛牛
Earnings Recap: Can Qiagen NV sustain its profitabilityPortfolio Gains Summary & Stepwise Trade Execution Plans - baoquankhu1.vn
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):